Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor α1 chain

被引:0
|
作者
Thirumalai R Ramalingam
John T Pesce
Faruk Sheikh
Allen W Cheever
Margaret M Mentink-Kane
Mark S Wilson
Sean Stevens
David M Valenzuela
Andrew J Murphy
George D Yancopoulos
Joseph F Urban
Raymond P Donnelly
Thomas A Wynn
机构
[1] Laboratory of Parasitic Diseases,Division of Therapeutic Proteins
[2] National institutes of Allergy and Infectious Diseases,United States Department of Agriculture
[3] Center for Drug Evaluation and Research,undefined
[4] Food and Drug Administration,undefined
[5] Biomedical Research Institute,undefined
[6] Regeneron Pharmaceuticals,undefined
[7] Diet,undefined
[8] Genomics,undefined
[9] and Immunology Laboratory,undefined
[10] Beltsville Human Nutrition Research Center,undefined
[11] Agricultural Research Service,undefined
来源
Nature Immunology | 2008年 / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The interleukin 4 receptor (IL-4R) is a central mediator of T helper type 2 (TH2)–mediated disease and associates with either the common γ-chain to form the type I IL-4R or with the IL-13R α1 chain (IL-13Rα1) to form the type II IL-4R. Here we used Il13ra1−/− mice to characterize the distinct functions of type I and type II IL-4 receptors in vivo. In contrast to Il4ra−/− mice, which have weak TH2 responses, Il13ra1−/− mice had exacerbated TH2 responses. Il13ra1−/− mice showed much less mortality after infection with Schistosoma mansoni and much more susceptibility to Nippostrongylus brasiliensis. IL-13Rα1 was essential for allergen-induced airway hyperreactivity and mucus hypersecretion but not for fibroblast or alternative macrophage activation. Thus, type I and II IL-4 receptors exert distinct effects on immune responses.
引用
收藏
页码:25 / 33
页数:8
相关论文
共 50 条
  • [21] Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome
    Cannon, JG
    Angel, JB
    Abad, LW
    Vannier, E
    Mileno, MD
    Fagioli, L
    Wolff, SM
    Komaroff, AL
    JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (03) : 253 - 261
  • [23] Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice
    Hirsch, E
    Irikura, VM
    Paul, SM
    Hirsh, D
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) : 11008 - 11013
  • [24] Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy
    Lorenzo, JA
    Naprta, A
    Rao, Y
    Alander, C
    Glaccum, M
    Widmer, M
    Gronowicz, G
    Kalinowski, J
    Pilbeam, CC
    ENDOCRINOLOGY, 1998, 139 (06) : 3022 - 3025
  • [25] THE INHIBITORY ACTIVITY OF HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IS ENHANCED BY TYPE-II INTERLEUKIN-1 SOLUBLE RECEPTOR AND HINDERED BY TYPE-I INTERLEUKIN-1 SOLUBLE RECEPTOR
    BURGER, D
    CHICHEPORTICHE, R
    GIRI, JG
    DAYER, JM
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01): : 38 - 41
  • [26] Interleukin 13 receptor alpha' chain is a functional component of interleukin 4 receptor and JAK2 is required for its signal transduction.
    Murata, T
    Taguchi, J
    Puri, RK
    BLOOD, 1997, 90 (10) : 741 - 741
  • [27] INTERLEUKIN-2 RECEPTOR GAMMA-CHAIN - A FUNCTIONAL COMPONENT OF THE INTERLEUKIN-4 RECEPTOR
    RUSSELL, SM
    KEEGAN, AD
    HARADA, N
    NAKAMURA, Y
    NOGUCHI, M
    LELAND, P
    FRIEDMANN, MC
    MIYAJIMA, A
    PURI, RK
    PAUL, WE
    LEONARD, WJ
    SCIENCE, 1993, 262 (5141) : 1880 - 1883
  • [28] INTERLEUKIN-1 RECEPTOR ANTAGONIST BINDS TO THE TYPE-II INTERLEUKIN-1 RECEPTOR ON B-CELLS AND NEUTROPHILS
    DRIPPS, DJ
    VERDERBER, E
    NG, RK
    THOMPSON, RC
    EISENBERG, SP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (30) : 20311 - 20315
  • [29] Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: A surface ''receptor'' with anti-interleukin-1 function
    Re, F
    Sironi, M
    Muzio, M
    Matteucci, C
    Introna, M
    Orlando, S
    PentonRol, G
    Dower, SK
    Sims, JE
    Colotta, F
    Mantovani, A
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04): : 1841 - 1850
  • [30] INTERLEUKIN 13 RECEPTOR ALPHA 1 KNOCKOUT NONOBESE DIABETIC MICE ARE PROTECTED FROM TYPE 1 DIABETES
    VanMorlan, A.
    Rowland, L.
    Wan, X.
    Zaghouani, H.
    PEDIATRIC RESEARCH, 2011, 70 (04) : 426 - 426